CareRx Corporation Stock

Equities

CRRX

CA14173C1059

Drug Retailers

Market Closed - Toronto S.E. 03:44:35 2024-05-17 pm EDT 5-day change 1st Jan Change
2.12 CAD 0.00% Intraday chart for CareRx Corporation +4.43% +31.68%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 366M 269M Sales 2025 * 387M 284M Capitalization 128M 93.64M
Net income 2024 * -2M -1.47M Net income 2025 * -2M -1.47M EV / Sales 2024 * 0.35 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.33 x
P/E ratio 2024 *
51.3 x
P/E ratio 2025 *
12.6 x
Employees 1,559
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.57%
More Fundamentals * Assessed data
Dynamic Chart
CareRx Brief: Company Undertaking a search for a new CFO; Davide Pernarella, currently Vice President, Business Planning and Analysis at CareRx, will assume the role of Interim CFO MT
CareRx Brief: Says Andrew Mok will step down as Chief Financial Officer effective June 7, 2024, to pursue another employment opportunity MT
Transcript : CareRx Corporation, Q1 2024 Earnings Call, May 10, 2024
CareRx Q1 Net Loss Narrows, Revenue Dips MT
CareRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
CareRx Brief: Q1 Revenue $89.7 million; Net loss for the quarter was $0.5 million MT
North American Morning Briefing : Stocks Set to -2- DJ
CareRx Down 3% as Notes Ontario Government's Pause of Planned Fee Changes MT
CareRx Brief: Notes Ontario Government's Pause of Planned Fee Changes MT
CareRx Brief: In connection with Prior announced normal course issuer bid to Buy Up To 1 Million of its common shares, it has entered into an automatic share purchase plan MT
CareRx Narrows Q4 Loss, Revenue Falls MT
Transcript : CareRx Corporation, Q4 2023 Earnings Call, Mar 07, 2024
CareRx Brief: Revenue for Q4 $91.1 million; Net loss for the quarter was $3.7 million MT
CareRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023 CI
More news
1 week+4.43%
Current month-10.17%
1 month-3.64%
3 months+36.77%
6 months+54.74%
Current year+31.68%
More quotes
1 week
2.01
Extreme 2.01
2.15
1 month
2.01
Extreme 2.01
2.42
Current year
1.45
Extreme 1.45
2.42
1 year
1.10
Extreme 1.1
2.43
3 years
1.10
Extreme 1.1
6.94
5 years
1.10
Extreme 1.1
6.94
10 years
1.10
Extreme 1.1
18.20
More quotes
Managers TitleAgeSince
Chief Executive Officer - 20-10-31
Director of Finance/CFO - 16-12-31
Chief Operating Officer - -
Members of the board TitleAgeSince
Chairman 56 17-03-29
Director/Board Member - 20-05-06
Director/Board Member - 21-05-31
More insiders
Date Price Change Volume
24-05-17 2.12 0.00% 16,200
24-05-16 2.12 +1.44% 8,900
24-05-15 2.09 -1.88% 8,124
24-05-14 2.13 +4.41% 49,044
24-05-13 2.04 +0.49% 17,600

Delayed Quote Toronto S.E., May 17, 2024 at 03:44 pm EDT

More quotes
CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.12 CAD
Average target price
3.781 CAD
Spread / Average Target
+78.36%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW